Y030-1349 Screening compound: N-(1-benzylpiperidin-4-yl)-2-fluorobenzamide

Y030-1349 Screening compound: N-(1-benzylpiperidin-4-yl)-2-fluorobenzamide
Y030-1349 Screening compound: N-(1-benzylpiperidin-4-yl)-2-fluorobenzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound Y030-1349
N-(1-benzylpiperidin-4-yl)-2-fluorobenzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

Y030-1349

Molecular Formula

C19H21FN2O (C19 H21 FN2 O)

Compound Name

N-(1-benzylpiperidin-4-yl)-2-fluorobenzamide

IUPAC name

N-(1-benzylpiperidin-4-yl)-2-fluorobenzamide

SMILES

O=C(c(cccc1)c1F)NC1CCN(Cc2ccccc2)CC1

InChI

InChI=1S/C19H21FN2O/c20-18-9-5-4-8-17(18)19(23)21-16-10-12-22(13-11-16)14-15-6-2-1-3-7-15/h1-9,16H,10-14H2,(H,21,23)

InChI Key

MKPUKJMUGJQSHO-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD00981151

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

312.39

Hydrogen Bond Acceptors Count

3.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

3

Partition Coefficient, logP

3.215

Distribution Coefficient, logD

1.769

Water Solubility, LogSw

-3.70

Polar Surface Area

27.917

Acid Dissociation Constant (pKa)

13.89

Base Dissociation Constant (pKb)

8.83

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

31.60

Y030-1349 in Drug Discovery

Included in Screening Libraries

3D-Biodiversity Library (27607 compounds)

Anti-Aging Library (44940 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

CNS Targets (44014 compounds)

Human Receptors Annotated Library (5376 compounds)

Launched & Clinically Evaluated Drugs Library (185 compounds)

Selective Target Activity Profiling Library (14702 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Target Identification, Phenotypic Screening library (TIPS) (27612 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Metabolic
  • Immune system
  • Nervous system
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Mechanism of action:
  • Epigenetic
Targets:
  • Proteases

References: we are preparing a list of scientific research reports with Y030-1349 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound Y030-1349?
Check Price and Availability of Y030-1349, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of Y030-1349 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for Y030-1349
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for Y030-1349
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of Y030-1349 available by request